TEXT +-

Clinician Perspectives

Through the MacTel Project, the Lowy Medical Research Institute works closely with an international group of clinicians.  These are individuals who may study MacTel through clinical or laboratory work.  Many see  patients with Macular Telangiectasia type 2 through the MacTel Project Registry and their clinical practices.  They have considerable experience diagnosing MacTel, and are working to improve our understanding of the disease.

These interviews feature information about the clinical research LMRI supports and recent clinical advances.

Interview with Alan Bird, MD

September 2016

Dr. Alan Brid, MD is a member of the Lowy Medical Research Institute’s Board of Scientific Governors. He is Professor Emeritus at The Institute of Ophthalmology London and the Moorfields Eye Hospital. His work has had a major impact on treating blindness around the world, and he has received a number of awards and accolades for his contributions to vision science. Dr. Bird has worked with numerous fellows at Moorfields on multidisciplinary clinical research projects, including molecular genetics, cell biology, electrophysiology, psychophysics, specialized imaging, and morphology. He spent time in Africa researching River Blindness; the results of his studies changed the course of disease management. He has also studied sickle retinopathy in Jamaica, where he demonstrated the relatively benign nature of that disease. Dr. Bird has published widely, having written more than 370 papers published in peer-reviewed journals, and over 70 book chapters. In this interview, we spoke about his involvement in MacTel research and the MacTel Project.
Read More

Interview with Emily Y. Chew, MD

June 2016

Dr. Emily Y. Chew, MD is the Deputy Director of the Division of Epidemiology and Clinical Applications at the National Eye Institute, National Institutes of Health. She is involved in the MacTel Project as the Director of the Clinical Projects for the Lowy Medical Research Institute. In this role, she coordinates and plans studies including the natural history study to understand the course of disease, and to study the factors that might be associated with the disease. She also helps to plan the clinical trials that test various therapies that might be used for MacTel type 2 eye disease.
Read More

Interview with Paul Bernstein, MD, PhD

April 2015

Dr. Paul Bernstein is a Professor at the University of Utah, School of Medicine, in the Department of Ophthalmology. Dr. Bernstein is a Lowy Medical Research Institute extramural investigator and clinical researcher. He has been instrumental to MacTel genetics research; recruiting families with MacTel to participate in the MacTel Project. In the laboratory, his research focuses on macular pigment. Changes in macular pigment distribution are among the first clinical signs of MacTel. In this interview, we discuss both his clinical and laboratory work.
Read More

United Kingdom

Moorfields Eye Hospital
London, United Kingdom
Cathy Egan, MD
011 44 20 7566 2262
catherine.egan@moorfields.nhs.uk

×
United States

California

Scripps Research Institute
La Jolla, CA USA
Martin Friedlander, MD, PhD
858-784-9138
friedlan@scripps.edu

Jules Stein Eye Institute, UCLA
Los Angeles, CA USA
Jean-Pierre Hubschman, MD
310-206-5004
hubschman@jsei.ucla.edu

Florida

Bascom Palmer Eye Institute, University of Miami
Miami, FL USA
Philip Rosenfeld, MD
305-326-6538
prosenfeld@med.miami.edu

Massachusetts

Massachusetts Eye and Ear Infirmary
Boston, MA USA
Joan Miller, MD
617-578-3257
joan.miller@meei.harvard.edu

Michigan

University of Michigan, Kellogg Eye Center
Ann Arbor, MI USA
Grant Comer, MD
734-763-5906
gcomer@umich.edu

New York

Manhattan Eye, Ear & Throat Hospital
New York, NY USA
Michael Cooney, MD
212 861-9797
m.cooney@vrmny.com

The New York Eye and Ear Infirmary
New York, NY USA
Richard Rosen, MD
212-979-4284
rrosen@nyee.edu

Ohio

Retina Associates of Cleveland, Inc.
Cleveland, OH USA
Lawrence Singerman, MD
216-831-5700
lsingerman@retina-assoc.com

Pennsylvania

Scheie Eye Institute
Philadelphia, PA USA
Alexander Brucker, MD
215-662-8675
ajbrucke@mail.med.upenn.edu

Utah

University of Utah Medical Center
Salt Lake City, Utah
Paul Bernstein, MD, PhD.
801-581-6078
paul.bernstein@hsc.utah.edu

Virginia

The Retina Group of Washington
Fairfax, VA USA
Robert Murphy, MD
703-698-9335
rpmurphy@comcast.net

Wisconsin

University of Wisconsin
Madison, WI USA
Barbara Blodi, MD
608-263-6646
bablodi@wisc.edu

×
France

Hopital Lariboisiere
Paris, France
Alain Gaudric, MD
011 33 1 4995 2475
alain.gaudric@lrb.aphp.fr

×
Germany

Universitats-Augenklinik Bonn
Bonn, Germany
Frank Holz, MD
011 49 228 287 5647
Frank.Holz@ukb.uni-bonn.de

St. Franziskus Hospital
Muenster, Germany
Prof. Daniel Pauleikhoff
dapauleikhoff@muenster.de
Bjorn Padge, MD
011 49-251-93308-0
bjoern@padge.de

×
Israel

The Goldschleger Eye Institute
Tel Hashomer, Israel
Joseph Moisseiev, MD
011 972 3 5343462
Joseph.moisseiev@sheba.health.gov.il

×
Switzerland

Klinik und Poliklinik fur Augenheilkunde
Inselspita
University of Bern
Bern, Switzerland
Sebastian Wolf, MD, PhD
41 31 6328503
sebastian.wolf@insel.ch

×
Australia

Center for Eye Research Australia
Melbourne, Australia
Robyn Guymer, MD
011 61 3 9929 8393
rhg@unimelb.edu.au

Lions Eye Institute
Nedlands, Australia
Ian Constable, MD
011 61 8 9381 0882
ijc@cyllene.uwa.edu.au

Save Sight Institute
Sydney NSW Australia
Mark Gillies, MD, PhD
011 61 412 060 313
mark.gillies@sydney.edu.au

×